SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Janux Therapeutics, Inc. (JANX) News

Track canonical SquawkNews coverage tagged to JANX, Janux Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol JANX Asset equity Sector Markets 90 days 1 Last 16.12 Updated Jun 25, 2026, 02:10 PM UTC Open live news feed
M JANX: Truist Assumes Buy Truist Securities analyst assumes Janux Therapeutics with a Buy rating and lowers Price Target to $26 EQUITY | Jun 25, 2026, 02:10 PM UTC